🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementFAERS pharmacovigilance data for semaglutide — anyone have experience? Page 5

FAERS pharmacovigilance data for semaglutide — anyone have experience?

bri_stats Mon, Dec 25, 2023 at 2:29 PM 36 replies 2,800 viewsPage 5 of 8
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Dec 25, 2023 at 9:34 PM#21

+1. This mirrors my journey exactly. The FAERS pharmacovigila discussion here is so valuable.

5 7LipidDoc_ATL, BariatricNurseD, MASHdoc_SA and 2 others
Reply Quote Save Share Report
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Dec 25, 2023 at 9:51 PM#22

Slightly tangential to FAERS pharmacovigilance but MeganSA_TX reminded me — has anyone else noticed changes in their alcohol tolerance?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

10 16NurseKim_ATL, paul_denver, TinaHashiRN and 7 others
Reply Quote Save Share Report
JakeSmashed95
Member
412
1,890
Aug 2024
Arkansas
Online
Dec 25, 2023 at 10:08 PM#23

Saving this for reference. Top-tier content.

45 13alex_tucson, kevin_tulsa, Dr.PainCLE and 42 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Dec 25, 2023 at 10:25 PM#24

Slightly tangential to FAERS pharmacovigilance but MeganSA_TX reminded me — what is the latest on the oral formulations?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

33 13james_edin, FranDenver, Dr.BariatricHTX and 30 others
Reply Quote Save Share Report
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Dec 25, 2023 at 10:42 PM#25

Relevant to FAERS pharmacovigilance data — here is my latest bloodwork comparison:

Key improvements: A1C 7.2% → 5.3%, triglycerides 215 → 115 mg/dL, hsCRP 6.0 → 0.9 mg/L. All on tirzepatide for 7 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

50 13jason_sac26, chris_chi24, tampaLisa73 and 47 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register